Tuesday, October 15, 2024 3:18:22 PM
EXEL wins the patent dispute with MSN laboratories so their patent protection is secure through 2030. The MSN patent lawsuit has been a weight on EXEL's stock price. Could see continued upward price movement this week and beyond.
https://finance.yahoo.com/news/exelixis-announces-second-patent-litigation-175700922.html
https://finance.yahoo.com/news/exelixis-announces-second-patent-litigation-175700922.html
Recent EXEL News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/26/2026 08:09:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 09:01:45 PM
- Exelixis Announces Presentations at ASCO 2026 Highlighting Ongoing Studies in Diverse Tumor Types • Business Wire • 05/21/2026 09:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/20/2026 08:31:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 10:58:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 10:58:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 10:58:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 10:58:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 10:58:25 PM
- Exelixis Announces Clinical Development Collaboration with Merck for Phase 3 STELLAR-316 Pivotal Trial for Patients with Colorectal Cancer • Business Wire • 05/19/2026 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/18/2026 08:49:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/18/2026 08:23:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/14/2026 08:30:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 11:03:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 11:03:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 11:03:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 11:03:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2026 08:39:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2026 08:36:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2026 08:07:20 PM
- Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May • Business Wire • 05/07/2026 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2026 08:11:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 08:07:51 PM
- Exelixis Announces First Quarter 2026 Financial Results and Provides Corporate Update • Business Wire • 05/05/2026 08:05:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/29/2026 10:49:54 PM
